Gofen & Glossberg’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-109,153
Closed -$23.2M 478
2014
Q4
$23.2M Sell
109,153
-3,543
-3% -$705K 1% 27
2014
Q3
$20.1M Sell
112,696
-9,676
-8% -$1.61M 0.89% 32
2014
Q2
$20.7M Sell
122,372
-13,005
-10% -$2.02M 0.91% 29
2014
Q1
$17.2M Buy
135,377
+1,239
+0.9% +$151K 0.8% 38
2013
Q4
$14.9M Buy
134,138
+8,053
+6% +$769K 0.7% 41
2013
Q3
$11.4M Buy
126,085
+4,599
+4% +$413K 0.59% 52
2013
Q2
$10.2M Buy
+121,486
New +$12.6M 0.55% 56

Other funds holding AGN

Gofen & Glossberg's AGN Position: Q1 2015 in Review

Gofen & Glossberg sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 109,153 shares — an estimated $23.2M sold.

Gofen & Glossberg first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $23.2M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Gofen & Glossberg reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Gofen & Glossberg sold 109,153 Allergan Inc shares in Q1 2015, an estimated $23.2M.
  • Gofen & Glossberg first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Gofen & Glossberg's Allergan Inc position peaked at $23.2M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Gofen & Glossberg's 13F filing for Q1 2015, filed 15 Apr 2015.